HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
1 - 2 of 2
Dova Study for Children with Immune Thrombocytopenia (ITP)
The Dova study is for children below 18 years with primary Immune Thrombocytopenia (ITP) who have had an insufficient response to previous treatment.
Related PI: Michele Lambert, MD, MSTR
UX053 in GSD III
Our team at the Congenital Hyperinsulinism Center at CHOP is working on a clinical drug trial that involves giving you a study drug called UX033.
Related PI: Diva D. De León-Crutchlow, MD, MSCE
Related Conditions: Metabolic Disease, Metabolic Disorders, Endocrinology Disorders, Hyperinsulinism, Hypoglycemia, Clinical Research, Clinical Trials, Rare Disorder Natural History Studies and Clinical Trials, Rare Genetic Disorders, Diabetes and other Metabolic Diseases, Rare Disease, Genetic Disease, Genetic Disorders